Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Found 2109 records

$172,500.00

Jan 1, 2012
Description:

The use of Next Generation Exome sequencing in the identification of genes responsible for rare childhood neurologic disorders

Organization: Canadian Institutes of Health Research
Location: Montréal, Quebec, CA H3T 1C5

$391,560.00

Dec 1, 2011
Description:

The Role of Cell Survival Genes in Neurogenesis and Neural Regeneration

Organization: Canadian Institutes of Health Research
Location: St. John's, Newfoundland & Labrador, CA A1C 5S7

$965,000.00

Nov 1, 2011

For-profit organization

Agreement:

509585

Agreement Number:

509585

Duration: from Nov 1, 2011 to Dec 31, 2013
Description:

Trillium Therapeutics is a biotechnology company specializing in innovative therapies of immunology and ctyoprotection. Funds will help commercialize a therapeutic treatment for interstitial cystitis.

Organization: Innovation, Science and Economic Development Canada
Program Name: Federal Economic Development Department for Ontario
Location: Mississauga, Ontario, CA M9W4Y9

$733,985.00

Oct 1, 2011
Description:

Investigation into the molecular mechanisms mediating excitotoxicity - developing novel post-stroke therapies

Organization: Canadian Institutes of Health Research
Location: Vancouver, British Columbia, CA V6T 1Z1

$339,058.00

Oct 1, 2011
Description:

Advancing gel dosimetry for clinical radiation therapy

Organization: Canadian Institutes of Health Research
Location: Kingston, Ontario, CA K7L 3N6

$293,267.00

Oct 1, 2011
Description:

Bone marrow-derived stem cell-based gene therapy to accelerate fracture healing

Organization: Canadian Institutes of Health Research
Location: Toronto, Ontario, CA M5B 1W8

$506,269.00

Oct 1, 2011
Description:

Pilot study of highly active anti-retroviral therapy for patients with primary biliary cirrhosis

Organization: Canadian Institutes of Health Research
Location: Edmonton, Alberta, CA T6G 2E1

$810,974.00

Oct 1, 2011
Description:

Chromatin modulation associated with gene regulation: Interplay between histone chaperones and epigenetic marks

Organization: Canadian Institutes of Health Research
Location: Québec, Quebec, CA G1K 7P4

$791,150.00

Oct 1, 2011
Description:

Strategies for gene discovery in schizophrenia: subphenotypes, deep sequencing, and interactions

Organization: Canadian Institutes of Health Research
Location: Toronto, Ontario, CA M5S 2S1

$822,107.00

Oct 1, 2011
Description:

Evaluation of a new cognitive therapy (inference-based therapy) for the treatment of obsessional compulsive disorder

Organization: Canadian Institutes of Health Research
Location: Montreal, Quebec, CA H1N 3V2